Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Horowski

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Klinische Wochenschrift|April 2, 1990
[Terguride in hyperprolactinemia--experiences with 5 patients]C Wüster, A Scholz, A Schmelzle, et al.
Headache|May 1, 1977
Clinical effectiveness of lisuride hydrogen maleate: a double-blind trial versus methysergideW M Herrmann, R Horowski, K Dannehl, et al.
Neurology|March 1, 1995
An essay on Wilhelm von Humboldt and the shaking palsy: first comprehensive description of Parkinson's disease by a patientR Horowski, L Horowski, S Vogel, et al.
Life Sciences|November 29, 2005
Proterguride, a highly potent dopamine receptor agonist promising for transdermal administration in Parkinson's disease: interactions with alpha(1)-, 5-HT(2)- and H(1)-receptorsB Schurad, R Horowski, S Jähnichen, et al.
Acta Neurologica Scandinavica|June 1, 1991
Lisuride plus selegiline in the treatment of early Parkinson's diseaseG Nappi, E Martignoni, R Horowski, et al.
Acta Endocrinologica|September 1, 1979
Suppression of prolactin secretion by lisuride throughout the menstrual cycle and in hyperprolactinaemic menstrual disordersH G Bohnet, J P Hanker, R Horowski, et al.
Nuklearmedizin. Nuclear Medicine|August 1, 1991
[A preclinical study of the organ distribution and radiation dosage of radioiodinated iodolisuride]K Buchali, H Flade, B Johannsen, et al.
Clinical Neuropharmacology|October 1, 1989
A study of the cardiopressor effects of lisuride in the treatment of parkinsonism and pathological aging brainG Micieli, E Martignoni, G Bono, et al.
Clinical Neuropharmacology|October 1, 1991
Antagonist effect of terguride in Parkinson's diseaseS Ruggieri, F Stocchi, F Baronti, et al.
Functional Neurology|November 1, 1996
Lisuride and bromocryptine in L-Dopa stable-responder parkinsonian patients: a comparative, double-blind evaluation of cardiopressor and neurochemical effectsG Micieli, E Martignoni, A Cavallini, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Klinische Wochenschrift|April 2, 1990
[Terguride in hyperprolactinemia--experiences with 5 patients]C Wüster, A Scholz, A Schmelzle, et al.
Headache|May 1, 1977
Clinical effectiveness of lisuride hydrogen maleate: a double-blind trial versus methysergideW M Herrmann, R Horowski, K Dannehl, et al.
Neurology|March 1, 1995
An essay on Wilhelm von Humboldt and the shaking palsy: first comprehensive description of Parkinson's disease by a patientR Horowski, L Horowski, S Vogel, et al.
Life Sciences|November 29, 2005
Proterguride, a highly potent dopamine receptor agonist promising for transdermal administration in Parkinson's disease: interactions with alpha(1)-, 5-HT(2)- and H(1)-receptorsB Schurad, R Horowski, S Jähnichen, et al.
Acta Neurologica Scandinavica|June 1, 1991
Lisuride plus selegiline in the treatment of early Parkinson's diseaseG Nappi, E Martignoni, R Horowski, et al.
Acta Endocrinologica|September 1, 1979
Suppression of prolactin secretion by lisuride throughout the menstrual cycle and in hyperprolactinaemic menstrual disordersH G Bohnet, J P Hanker, R Horowski, et al.
Nuklearmedizin. Nuclear Medicine|August 1, 1991
[A preclinical study of the organ distribution and radiation dosage of radioiodinated iodolisuride]K Buchali, H Flade, B Johannsen, et al.
Clinical Neuropharmacology|October 1, 1989
A study of the cardiopressor effects of lisuride in the treatment of parkinsonism and pathological aging brainG Micieli, E Martignoni, G Bono, et al.
Clinical Neuropharmacology|October 1, 1991
Antagonist effect of terguride in Parkinson's diseaseS Ruggieri, F Stocchi, F Baronti, et al.
Functional Neurology|November 1, 1996
Lisuride and bromocryptine in L-Dopa stable-responder parkinsonian patients: a comparative, double-blind evaluation of cardiopressor and neurochemical effectsG Micieli, E Martignoni, A Cavallini, et al.
Pageof 8